[go: up one dir, main page]

CH553410A - PROCESS FOR THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF AN ORGANIC COMPOUND IN AN ENVIRONMENT LIKELY TO CONTAIN IT OR CONTAINER. - Google Patents

PROCESS FOR THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF AN ORGANIC COMPOUND IN AN ENVIRONMENT LIKELY TO CONTAIN IT OR CONTAINER.

Info

Publication number
CH553410A
CH553410A CH709772A CH709772A CH553410A CH 553410 A CH553410 A CH 553410A CH 709772 A CH709772 A CH 709772A CH 709772 A CH709772 A CH 709772A CH 553410 A CH553410 A CH 553410A
Authority
CH
Switzerland
Prior art keywords
qualitative
container
contain
environment
organic compound
Prior art date
Application number
CH709772A
Other languages
French (fr)
Original Assignee
Syva Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syva Co filed Critical Syva Co
Publication of CH553410A publication Critical patent/CH553410A/en
Priority to US05/649,942 priority Critical patent/US4039385A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CH709772A 1971-05-14 1972-05-12 PROCESS FOR THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF AN ORGANIC COMPOUND IN AN ENVIRONMENT LIKELY TO CONTAIN IT OR CONTAINER. CH553410A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US05/649,942 US4039385A (en) 1972-05-08 1976-01-19 Cardiac glycoside enzyme conjugates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14360971A 1971-05-14 1971-05-14

Publications (1)

Publication Number Publication Date
CH553410A true CH553410A (en) 1974-08-30

Family

ID=22504809

Family Applications (1)

Application Number Title Priority Date Filing Date
CH709772A CH553410A (en) 1971-05-14 1972-05-12 PROCESS FOR THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF AN ORGANIC COMPOUND IN AN ENVIRONMENT LIKELY TO CONTAIN IT OR CONTAINER.

Country Status (12)

Country Link
JP (1) JPS5327763B1 (en)
BR (1) BR7202989D0 (en)
CA (1) CA1003770A (en)
CH (1) CH553410A (en)
DE (1) DE2223385C3 (en)
ES (1) ES402720A1 (en)
FR (1) FR2139505A5 (en)
GB (2) GB1401297A (en)
IL (1) IL39323A (en)
IT (1) IT972332B (en)
NL (1) NL170564C (en)
SE (1) SE403190B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981001414A1 (en) * 1979-11-19 1981-05-28 Charles Hospital Dev An improved method of non homogenous enzyme immunoassay

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1028643A (en) * 1975-02-20 1978-03-28 Judith I. Blakemore Polylodothyronine immunoassay
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
US4220450A (en) * 1978-04-05 1980-09-02 Syva Company Chemically induced fluorescence immunoassay
DE2923139A1 (en) * 1979-06-07 1980-12-18 Boehringer Mannheim Gmbh METHOD FOR PRODUCING IMMUNOLOGICALLY ACTIVE ENZYMMARKED CONJUGATES
DE3361549D1 (en) * 1982-05-26 1986-01-30 Boots Celltech Diagnostics Immunoassay
GB8407736D0 (en) * 1984-03-26 1984-05-02 Univ London Detecting specific polynucleotide sequences
IT1178788B (en) * 1984-12-21 1987-09-16 Sclavo Spa IMMUNOENZYMATIC METHOD FOR THE DETERMINATION OF ANALYTES AND COMPOSITION SUITABLE FOR THE PURPOSE
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5137804A (en) * 1988-05-10 1992-08-11 E. I. Du Pont De Nemours And Company Assay device and immunoassay
US5374524A (en) * 1988-05-10 1994-12-20 E. I. Du Pont De Nemours And Company Solution sandwich hybridization, capture and detection of amplified nucleic acids
US5196306A (en) * 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
EP2418492B1 (en) * 2010-08-10 2018-10-10 Randox Laboratories Ltd. Immunoreagent for meprobamate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981001414A1 (en) * 1979-11-19 1981-05-28 Charles Hospital Dev An improved method of non homogenous enzyme immunoassay

Also Published As

Publication number Publication date
IL39323A0 (en) 1972-06-28
DE2223385A1 (en) 1973-01-04
FR2139505A5 (en) 1973-01-05
GB1401297A (en) 1975-07-16
SE403190B (en) 1978-07-31
IL39323A (en) 1975-08-31
IT972332B (en) 1974-05-20
NL170564B (en) 1982-06-16
CA1003770A (en) 1977-01-18
JPS5327763B1 (en) 1978-08-10
ES402720A1 (en) 1976-12-01
NL7206434A (en) 1972-11-16
DE2223385C3 (en) 1984-10-25
BR7202989D0 (en) 1973-11-01
GB1401298A (en) 1975-07-16
DE2223385B2 (en) 1979-02-22
NL170564C (en) 1982-11-16

Similar Documents

Publication Publication Date Title
AT314934B (en) Solution and method for the immediate activation of plastic surfaces for subsequent chemical metallization
CH550588A (en) DEVICE FOR MECHANICALLY DOSED APPLICATION OF LIQUID MEDICINAL PRODUCTS OR MEDICINAL SOLUTIONS.
CH553410A (en) PROCESS FOR THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF AN ORGANIC COMPOUND IN AN ENVIRONMENT LIKELY TO CONTAIN IT OR CONTAINER.
CH558747A (en) DEVICE FOR STORAGE AND REMOVAL OF GOODS.
CH551216A (en) Process for the encapsulation of a substance finely distributed in a liquid.
IT974628B (en) EQUIPMENT FOR CHEMICAL ANALYSIS OF BIOLOGICAL SUBSTANCES
NL181936C (en) METHOD FOR THE ENZYMKINETIC DETERMINATION OF THE CONCENTRATION OF A SUBSTRATE IN A LIQUID ENVIRONMENT.
BE822805A (en) PROCESS FOR PROTECTING THE VISUAL APPEARANCE OF AN ORGANIC COMPOUND AND ITS APPLICATIONS
AT323656B (en) CONTAINERS FOR TRUBBING (ROTATION) OF ORGANIC WASTE
NL168516C (en) METHOD FOR PREPARING A PHARMACEUTICALLY BASED ON A NITROGEN CONTAINED NITROGEN CONTAINING NITROGEN CONTAINED WITH A NITROGEN GROUP AND / OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREFOR AND ITS PROPERTY THEREFOR AND ITS PROCESS.
IT1041738B (en) REAGENT FOR THE ENZYMETIC DETERMINATION OF SUBSTRATES IN BIOLOGICAL LIQUIDS
IL33870A0 (en) The preservation of organic matter by biological protease inhibitors
SE397537B (en) COATING COMPOSITION CONTAINING VARMABLE ADDITION POLYMES DESPERGED IN ORGANIC LIQUID AND A BREWING HARD
CH519719A (en) Process for the pictorial recording of liquid flows along solid surfaces
AT339636B (en) DEVICE FOR COOLING LIQUID FUELS OR SIMILAR LIQUIDS
BE753025A (en) METHOD AND DEVICE FOR INTRODUCING EXPLOSIVES IN THE FORM OF GELS OR FORMING GELS INTO DRILL HOLES
NL154489B (en) PROCESS FOR OXYDERING HYDROCARBONS WITH MOLECULAR OXYGEN IN THE PRESENCE OF BORIC ACID.
IT997652B (en) PROCEDURE FOR IMPROVING THE UNLOADING OF FIXED OR PORTABLE CONTAINERS CONTAINING POWDERED OR GRANULATED LIQUID MATERIALS
AT336781B (en) SUBSTRATE SUITABLE FOR THE DETERMINATION OF DESOXYRIBONUCLEASE AND ITS ANTIBODIES
BE783635A (en) INORGANIC COMPOSITION CONTAINING ANTIMONY AND PROCESS FOR PREPARING IT
BE773054A (en) BINDER COMPOSITION AND CONTAINER COATING
BE751976A (en) TETRACHLORO-1,1,1,2-ETHANE DECOMPOSITION INHIBITOR OR MIXTURES OF ORGANIC CHLORINE COMPOUNDS IN CONTAINER
CH552005A (en) PROCESS FOR THE PREPARATION OF NEW DIGLYCIDYL DERIVATIVES OF NHETEROCYCLIC COMPOUNDS AND THEIR USE.
CH548989A (en) PROCESS FOR THE PRODUCTION OF FORMAMIDIN DERIVATIVES AND THEIR USE AS INSECTICIDES OR MITE-KILLING AGENTS.
CH552214A (en) METHOD FOR CARRYING OUT ANALYZES IN THE FIELD OF ORGANIC CHEMISTRY.

Legal Events

Date Code Title Description
PL Patent ceased